Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion type Assertion NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_head.
- NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion description "[Here, we investigated the oncolytic potential of two commercially available live attenuated vaccines, Moraten measles and Jeryl-Lynn mumps, in a murine model of intraperitoneal human ovarian cancer and compared their efficacies against a recombinant oncolytic measles virus (MV-CEA) that is being tested in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_provenance.
- NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion evidence source_evidence_literature NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_provenance.
- NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion SIO_000772 15746945 NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_provenance.
- NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion wasDerivedFrom befree-20150227 NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_provenance.
- NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_assertion wasGeneratedBy ECO_0000203 NP312264.RACcWNb6p80YWboH2YAAYkcSZV1Jp_SssxgrvLWtoAnH4130_provenance.